KM Pharmaceutical Largest Shareholder Kang Il-mo Slightly Increases Stake via Open Market Purchase and Partially Repays Pledged Loans
Kang Il-mo, the largest shareholder of KM Pharmaceutical, acquired an additional 1,650 shares through open market purchases on July 10, 2026, increasing his stake from 39.62% to 39.65%.
Kang has pledged 94,503 shares to IBK Investment & Securities and 1,100,000 shares to the Industrial Bank of Korea, totaling 1,194,503 shares or 21.42% of outstanding shares. Partial repayment of the IBK loan reduced the pledged shares.
Outstanding loan balances are 669 million KRW with IBK at 5.90% interest and 3.35 billion KRW with IBK at 4.34% interest.
[AI Summary]The marginal increase in stake by the largest shareholder is positive for management stability, but the high pledge ratio above 21% poses a risk of margin calls if the stock price declines. Near-term price impact is limited but long-term risk persists.